InvestorsHub Logo
Followers 239
Posts 12042
Boards Moderated 0
Alias Born 08/14/2003

Re: Dan88 post# 251694

Thursday, 11/14/2019 3:30:16 PM

Thursday, November 14, 2019 3:30:16 PM

Post# of 689011
A very well thought out post Dan,

In that I wasn't here when the trial halted, out of curiosity and from a standpoint of understanding the data, how long was it halted for, and when it was resumed, how long did it take to dose the last 31 patients, as I understand it, in the trial.

If the halt was for 6 months, and it took 6 months until the last patient entered the trial, it would mean that as of now, for the 300 who entered the trial prior to the halt, the last to be dosed there would now be 5 years beyond the initiation of treatment. I'm not saying these are the numbers, I'm asking what they should be, but the point I'm making is that with the exception of those who entered after the halt, most if not all are now survivors for roughly 5 years or more.

I suspect when we see the K-M, the big tail people speak about will really be impressive, and perhaps may extend out a decade or more is some of the earliest people to enter the trial are living or recently passed.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News